Abstract
Hepatitis C is a major cause of liver-related morbidity and mortality. A high proportion of patients never experience symptoms. Peginterferon plus ribavirin is the recommended treatment for chronic hepatitis C. However, ribavirin monotherapy may be considered for some patients.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Cochrane Database of Systematic Reviews |
Udgave nummer | 4 |
Sider (fra-til) | CD005527 |
ISSN | 1469-493X |
DOI | |
Status | Udgivet - 2009 |